enVVeno Medical Corp (NVNO) Current Ratio
- Current ratio · latest quarter: Value 11.70×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 11.70× | Current assets / current liabilities. $22.08M ÷ $1.89M ≈ 11.70× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 22.08M USD | Assets, Current |
| Current obligations | 1.89M USD | Liabilities, Current |
| Cash and equivalents | 2.84M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | |
| Payables | 540.00K USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $22.08M | $1.89M | $2.84M | (m) | (m) | (m) | $540.00K | (m) | 11.70× |
| 2026-03-31 | $25.49M | $2.14M | $2.60M | (m) | (m) | (m) | $813.00K | (m) | 11.89× |
| 2025-12-31 | $28.83M | $2.12M | $3.06M | (m) | (m) | (m) | $358.00K | (m) | 13.58× |
| 2025-09-30 | $31.50M | $2.40M | $1.54M | (m) | (m) | (m) | (m) | (m) | 13.12× |
| 2025-06-30 | $35.60M | $3.02M | $2.04M | (m) | (m) | (m) | (m) | (m) | 11.81× |
| 2025-03-31 | $39.48M | $1.66M | $2.94M | (m) | (m) | (m) | (m) | (m) | 23.77× |
| 2024-12-31 | $43.73M | $2.10M | $1.75M | (m) | (m) | (m) | $1.01M | (m) | 20.88× |
| 2024-09-30 | $49.05M | $2.23M | $17.91M | (m) | (m) | (m) | (m) | (m) | 22.01× |
| 2024-06-30 | $39.54M | $1.70M | $2.38M | (m) | (m) | (m) | (m) | (m) | 23.33× |
| 2024-03-31 | $43.25M | $1.49M | $2.31M | (m) | (m) | (m) | (m) | (m) | 29.08× |
| 2023-12-31 | $46.92M | $1.37M | $3.62M | (m) | (m) | (m) | (m) | (m) | 34.23× |
| 2023-09-30 | $26.22M | $2.03M | $4.95M | (m) | (m) | (m) | $1.70M | (m) | 12.91× |
| 2023-06-30 | $30.11M | $2.07M | $4.71M | (m) | (m) | (m) | $1.72M | (m) | 14.57× |
| 2023-03-31 | $34.52M | $1.17M | $2.27M | (m) | (m) | (m) | $847.00K | (m) | 29.58× |
| 2022-12-31 | $39.44M | $1.53M | $4.55M | (m) | (m) | (m) | (m) | (m) | 25.78× |
| 2022-09-30 | $40.71M | $1.30M | $2.90M | (m) | (m) | (m) | $501.00K | (m) | 31.22× |
| 2022-06-30 | $37.76M | $1.82M | $9.07M | (m) | (m) | (m) | $1.03M | (m) | 20.79× |
| 2022-03-31 | $51.65M | $1.27M | $51.34M | (m) | (m) | (m) | $557.00K | (m) | 40.67× |
| 2021-12-31 | $55.04M | $1.58M | $54.73M | (m) | (m) | (m) | $560.00K | (m) | 34.84× |
| 2021-09-30 | $58.21M | $1.12M | $57.90M | (m) | (m) | (m) | $394.19K | (m) | 52.06× |
| 2021-06-30 | $41.44M | $1.39M | $41.04M | (m) | (m) | (m) | $308.88K | (m) | 29.74× |
| 2021-03-31 | $44.17M | $1.87M | $43.84M | (m) | (m) | (m) | $709.24K | (m) | 23.57× |
| 2020-12-31 | $9.57M | $3.19M | $9.33M | (m) | (m) | (m) | $1.39M | (m) | 3.00× |
| 2020-09-30 | $5.98M | $1.92M | $5.63M | (m) | (m) | (m) | $974.23K | (m) | 3.12× |
| 2020-06-30 | $1.78M | $2.95M | $1.56M | (m) | (m) | (m) | $1.57M | (m) | 0.60× |
| 2020-03-31 | $840.14K | $2.25M | $720.13K | (m) | (m) | (m) | $1.40M | (m) | 0.37× |
| 2019-12-31 | $1.42M | $1.88M | $1.31M | (m) | (m) | (m) | $1.22M | (m) | 0.76× |
| 2019-09-30 | $3.06M | $2.02M | $2.94M | (m) | (m) | (m) | $1.21M | (m) | 1.52× |
| 2019-06-30 | $4.63M | $1.88M | $4.47M | (m) | (m) | (m) | $1.20M | (m) | 2.46× |
| 2019-03-31 | $2.95M | $1.84M | $2.75M | (m) | $26.52K | (m) | $1.10M | (m) | 1.60× |
| 2018-12-31 | $2.84M | $1.52M | $2.74M | (m) | $32.02K | (m) | $1.08M | (m) | 1.86× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |